MAM
PDSB icon

Meeder Asset Management’s PDS Biotechnology PDSB Stock Holding History

Meeder Asset Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17
Closed – – 1774
2018
Q3 		$0 Sell
17
-77
-82% -$1.38K ﹤0.01% 1650
2018
Q2 		$1.93K Buy
94
+65
+224% +$1.36K ﹤0.01% 1421
2018
Q1 		$1K Buy
29
+13
+81% +$3.5K ﹤0.01% 1467
2017
Q4 		$3K Buy
16
+3
+23% +$604 ﹤0.01% 1435
2017
Q3 		$3K Hold
13
– – ﹤0.01% 1382
2017
Q2 		$3K Hold
13
– – ﹤0.01% 1333
2017
Q1 		$2K Buy
+13
New +$2.58K ﹤0.01% 1391

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Meeder Asset Management's PDSB Position: Q4 2018 in Review

Meeder Asset Management sold out of PDS Biotechnology (PDSB) in Q4 2018, closing a stake of 17 shares.

Meeder Asset Management first reported a position in PDSB in Q1 2017 and held it in 7 quarters. The position peaked at $3K in Q4 2017. 31 funds tracked by Wall St. Rank hold PDSB as of Q4 2018.

  • Meeder Asset Management reported no remaining PDS Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Meeder Asset Management sold 17 PDS Biotechnology shares in Q4 2018.
  • Meeder Asset Management first reported a position in PDS Biotechnology in Q1 2017 and held it in 7 quarters.
  • Meeder Asset Management's PDS Biotechnology position peaked at $3K in Q4 2017.
  • 31 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2018.

Based on Meeder Asset Management's 13F filing for Q4 2018, filed 17 Jan 2019.